V-BOSE-M2 Tablets

Obtain Supercilious Glycemic Control

COMPOSITION – Voglibose IP 0.2 mg + Metformin Hydrochloride IP 500 mg (SR)

Category:

Description

  • In a 24-week study on Korean patients with Type 2 DM  and with inadequate glycemic control on diet and exercise, treatment with voglibose and metformin provided superior glycemic control for HbA1c, 2h-PPG, and FPG levels, greater weight loss, and less glycemic variability than did metformin monotherapy.

Composition

  • Voglibose IP 0.2 mg + Metformin Hydrochloride IP 500 mg (SR)